BioAffinity Technologies Inc

NASDAQ:BIAF 4:00:00 PM EDT

0.29

+0.03 (+10.06%)

: $0.30 +0.01 (+3.45%)

Market Cap (Intraday)	9.08M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$1.51 Million
Adjusted EPS	-$0.10

See more estimates

10-Day MA	$0.28
50-Day MA	$0.30
200-Day MA	$0.85

See more pivots

BioAffinity Technologies Inc Stock, NASDAQ:BIAF

3300 Nacogdoches Road, Suite 216, San Antonio, Texas 78217

United States of America

Phone: +1.210.698.5334

Number of Employees: 75

http://www.bioaffinitytech.com

Description

bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.